Chest and Abdominal Wall Strapping in Infant With Bronchiolitis (WRAPITIS)

July 30, 2025 updated by: Hospices Civils de Lyon

Effect of Chest and Abdominal Wall Strapping on Ventilation and Work of Breathing in Infants With Severe Bronchiolitis: a Physiological Study

Bronchiolitis is the most common cause of admission to the Paediatric Intensive Care Unit (PICU) for respiratory distress.

The care of an infant with severe bronchiolitis is mainly based on symptomatic treatment (nutritional and respiratory support). The lower part of an infant's chest is larger than that of an older child, which can flatten the diaphragm, especially in obstructive disease with air trapping. Strapping the lower part (at the junction of the chest and abdomen) may provide a better condition for diaphragmatic contraction. Based on respiratory mechanics in infants and physiological studies in adults, investigators hypothesise that chest wall strapping may improve the ventilation and the diaphragmatic contraction.

Infant < 6 month with severe bronchiolitis admitted to the PICU will be recorded in 4 conditions with or without chest wall strapping and with a Continuous Positive Airway Pressure (CPAP) at 7 cmH2O or without CPAP. Physiological parameters (including work of breathing, respiratory parameters, distribution of ventilation) will be recorded and analysed.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bron, France, 69500
        • Réanimation pédiatrique

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Infant < 6 months
  • Admitted to the PICU for less than 48 hours
  • With a diagnosis of bronchiolitis
  • With a respiratory distress sign (mWCAS ≥ 3) and non-invasive ventilatory support
  • With a naso or oro gastric tube for feeding
  • With written informed consent from parents or legal guardians

Exclusion Criteria:

  • Infants with severe bronchopulmonary disease, severe laryngomalacia, neuromuscular disease, bone disease, cyanotic heart disease
  • Contraindication to the use of a gastric tube
  • recent abdominal or thoracic surgery
  • investigator able to perform physiological recording not available
  • Patient who is not affiliated (or does not benefit from) to a national social security system

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Infant < 6 months with severe bronchiolitis

Infant will be recorded successively in 6 conditions (10 min each) :

  • Without chest wall strapping at PEEP 0 and PEEP 7
  • With chest wall strapping at PEEP 0 and PEEP 7
  • again without chest wall strapping at PEEP 0 and PEEP 7.
An elastic band (6 cm wide) is placed around the lower part of the chest wall (at the junction of the chest and abdomen) to tighten the chest wall for 10 min at PEEP 7 cmH2O and 10 min without PEEP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Esophagal product time pressure
Time Frame: 1 hour
Average over 100 consecutive cycles of esophageal product time pressure value
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diaphragmatic product time pressure
Time Frame: 1 hour
Average over 100 consecutive cycles of diaphragmatic product time pressure value
1 hour
Esophagal and diaphragmatic swing
Time Frame: 1 hour
Mean on 100 breaths of the amplitude (maximum value -minimum value) of the esophageal pressure (cmH2O) and gastric pressure (cmH2O)
1 hour
Distribution of ventilation : center of ventilation
Time Frame: 1 hour
Mean over 1 minute of the center of the ventilation (%). Center of ventilation represents the average of the dorsal-ventral distribution of tidal variation using Electrical Impedance Tomography (values >50% indicating that the center of ventilation is located in the ventral part of the chest)
1 hour
End expiratory lung volume
Time Frame: 1 hour
Average over 1 minute of the end expiratory lung impedance
1 hour
Time ratio
Time Frame: 1 hour
average over 100 consecutive cycles of inspiratory to aspiratory time ratio
1 hour
modified wood asthma score (mWCAS)
Time Frame: 1 hour

Value of the modified wood asthma score at the end of the recording period in each condition.

Minimal value 0 and maximal value 10. A score ≥ 3 mean a moderate-to-severe respiratory distress.

1 hour
TcPCO2
Time Frame: 1 hour
Average of the transcutaneous CO2 (carbon dioxide) partial over 1 minute
1 hour
EDIN scale (Newborn Pain and Discomfort Scale)
Time Frame: 1 hour
Value of the EDIN score at the end of the recording period in each condition. Minimal value 0 and maximal value 15. EDIN scores > 6 are considered expression of pain
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2023

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

September 25, 2023

First Submitted That Met QC Criteria

October 12, 2023

First Posted (Actual)

October 13, 2023

Study Record Updates

Last Update Posted (Actual)

August 3, 2025

Last Update Submitted That Met QC Criteria

July 30, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bronchiolitis

Clinical Trials on Chest wall strapping

Subscribe